Read now this fantastic article from Manila Bulletin "Finding hope in precision. More hope for patients with brain tumor using CyberKnife" and learn more on the benefits of the #CyberKnife System for the patients. mb.com.ph/2025/06/01/fin… #AccurayExpandRT

#WRAD may have passed, but the momentum continues! Let's keep celebrating the power of radiotherapy. 📅 Sept. 29th 3:30 PM 📍 Booth 525 #ASTRO25 🎤 Lucinda Morris, M.D. “One Voice for Radiotherapy: Celebrating the First World Radiotherapy Awareness Day” 🔗ow.ly/Jxlb50X1iWF

Ralph Weichselbaum MD Anderson Cancer Center GU005 allowed hotspots of 38.7 Gy. PACE-B allowed hotspots of 48-50 Gy. So there is a 13 Gy eqd2 difference even between prescription doses and even more when accounting for hotspots. Thus GU005 had a bit more BCR but lower tox. PACE-B had a little better BCR and more tox.

Back from #ASTRO2025 in San Francisco. Air New Zealand landed on time, friendly customs and quarantine, on a Uber to clinic in <15 mins. I❤️NZ

Huge thanks to Seth Blacksburg, M.D, MBA and his team at Accuray for organising the SABR symposium. It was great to meet again Sean Collins Prostate SBRT @ USF Health Shankar Siva and make acquaintance with stellar experts JimmGrimm Kristin Redmond. Arrivederci 😊

Congrats to Shankar Siva on presenting new pooled analysis from the FASTRACK & FASTRACK II trials at #ASTRO25. The data support the use of ultra-hypofractionated SABR schedules for renal cell carcinoma. Read about TROG 15.03/ANZUP 16001 – FASTRACK II : ap1.hubs.ly/y0hXDT0

ESMO 2024 Quick Take Insights: Prostate Cancer - #ARANOTE: Darolutamide + ADT shows significant rPFS benefits in mHSPC, offering a new treatment without docetaxel. - #PEACE3Study: Radium-223 + enzalutamide in mCRPC enhances rPFS & OS when used with bone protection in patients

1/2 Just published in JAMA Oncology: 15-year outcomes of Active Monitoring, Surgery, and Radiotherapy for cribriform-positive and cribriform-negative prostate cancer in the ProtecT trial. Secondary analysis based on centralised biopsy review🔬 Article: jamanetwork.com/journals/jamao…

🚨Important update from ProtecT #ProstateCancer trial after central pathology review 1️⃣ Which early PCa need treatment? Which do not? 2️⃣ For “bad” early PCa, do RP or RT prevent long-term (15y) metastasis? 🧵1/ OncoAlert UroToday.com PCF Science JAMA Oncology European Association of Urology (EAU) Amer. Urol. Assn.

📢#ESMO25 Alexandros Papachristofilou presents long-term data from SAKK 01/10: 1x carboplatin (AUC7) + involved-node RT (30–36 Gy) for stage IIA/B seminoma new SOC? 👨‍⚕️ n=116 | FU: 8.1y 🔹 10y PFS: 92.8% 🔹 OS: 99.1% | CSS: 100% 🔹 Minimal late toxicity | No in-field 2° cancers ✅ Durable,

Important data 👇

When you SABR it - do it right! sciencedirect.com/science/articl…

Radiation oncologists are trained to deliver safe, high-precision radiotherapy as part of a #cancer care team. We follow the best available evidence & develop customized, cost-effective plans. Science guides our treatments, but humanity guides our practice. 1/2

I don’t think Joe Biden could have found a better doctor to take care of him than Neha Vapiwala Penn Medicine. The best of the best! 👏

Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer - PubMed pubmed.ncbi.nlm.nih.gov/41105052/

Sorry to miss a spectacular #SABR2025 but this weekend the keynote 🎶 on stage in #auckland was Lenny Kravitz 🎸Drew Moghanaki Shankar Siva Pierre Blanchard, MD